Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region

Detalhes bibliográficos
Autor(a) principal: Marinho, Maria Gorete Lima
Data de Publicação: 2022
Outros Autores: Cândido, Suzany Helena da Silva, Oliveira, Mírian Brasil Magalhães de, Badin, Rebeka Caribé
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/27592
Resumo: The indiscriminate and excessive use of antimicrobials directly contributes to the development of bacterial resistance, increasing treatment expenses, morbidity and mortality rates, hospitalization time, and various adverse reactions. Therefore, the study's objective was to evaluate and quantify the consumption of antimicrobials used in the ICU of a Federal Public Hospital. Antimicrobial consumption was expressed as a defined daily dose (DDD) per 1000 patients/day. It was used in the World Health Organization (WHO) ATC/DDD classification. A total of 190 patients were admitted to the Intensive Care Unit, among which 51% were male, with a mean age of 53.4 ± 17.76 years, with the most prevalent age group being between 60 and 74 years (30.5 %). Among the diagnostic hypotheses of hospitalization, 26% were coronavirus infections. Of the hospitalized patients, 35.71% used some antimicrobial treatment, with meropenem being the most consumed (DDD 225.24). The study of the use of antimicrobials is an essential tool to guide the actions of the SCIH (Hospital Infection Control Service) that minimize microbial resistance and the indiscriminate and irrational use of these drugs and for the economic aspect. Furthermore, implementing an antimicrobial stewardship program optimizes the safe use of this important class of drugs.
id UNIFEI_aec1d7849cf17a47aef19dfc6d65c971
oai_identifier_str oai:ojs.pkp.sfu.ca:article/27592
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North RegionEstudio de consumo de antimicrobianos en el Centro de Cuidados Intensivos de un Hospital Universitario de la Región NorteEstudo de consumo de antimicrobianos do Centro de Terapia Intensiva de um hospital Universitário da Região Norte Unidad de Cuidados IntensivosConsumo de antimicrobianosMultirresistencia microbiana.Intensive Care CenterAntimicrobial consumptionMicrobial resistance.Unidade de Terapia IntensivaConsumo de antimicrobianosMultirresistência microbiana.The indiscriminate and excessive use of antimicrobials directly contributes to the development of bacterial resistance, increasing treatment expenses, morbidity and mortality rates, hospitalization time, and various adverse reactions. Therefore, the study's objective was to evaluate and quantify the consumption of antimicrobials used in the ICU of a Federal Public Hospital. Antimicrobial consumption was expressed as a defined daily dose (DDD) per 1000 patients/day. It was used in the World Health Organization (WHO) ATC/DDD classification. A total of 190 patients were admitted to the Intensive Care Unit, among which 51% were male, with a mean age of 53.4 ± 17.76 years, with the most prevalent age group being between 60 and 74 years (30.5 %). Among the diagnostic hypotheses of hospitalization, 26% were coronavirus infections. Of the hospitalized patients, 35.71% used some antimicrobial treatment, with meropenem being the most consumed (DDD 225.24). The study of the use of antimicrobials is an essential tool to guide the actions of the SCIH (Hospital Infection Control Service) that minimize microbial resistance and the indiscriminate and irrational use of these drugs and for the economic aspect. Furthermore, implementing an antimicrobial stewardship program optimizes the safe use of this important class of drugs.El uso indiscriminado y excesivo de antimicrobianos contribuye directamente al desarrollo de resistencias bacterianas, aumentando los gastos de tratamiento, las tasas de morbilidad y mortalidad, el tiempo de hospitalización y la ocurrencia de diversas reacciones adversas. El objetivo del estudio fue evaluar y cuantificar el consumo de antimicrobianos utilizados en la UTI de un Hospital Público Federal. Estudio descriptivo, transversal y retrospectivo realizado en la Unidad de Cuidados Intensivos (UCI) de un Hospital Universitario Federal de la región Norte, de enero a diciembre de 2020. El consumo de antimicrobianos se expresó como dosis diaria definida (DDD) por 1000 pacientes/día. Se utilizó la clasificación ATC/DDD de la Organización Mundial de la Salud (OMS). Un total de 190 pacientes ingresaron en la Unidad de Cuidados Intensivos, de los cuales el 51 % eran del sexo masculino, con una edad promedio de 53,4 ± 17,76 años, siendo el grupo de edad más prevalente el de 60 a 74 años (30,5 %). ntre las hipótesis diagnósticas de hospitalización, el 26% fueron infección por coronavirus. De los pacientes hospitalizados, el 35,71% utilizaba algún tipo de tratamiento antimicrobiano, siendo el meropenem el más consumido (DDD 225,24). El estudio del uso de antimicrobianos es una herramienta importante tanto para orientar las acciones del SCIH (Servicio de Control de Infecciones Hospitalarias) que minimicen la resistencia microbiana y el uso indiscriminado e irracional de estos fármacos, como por el aspecto económico. Además, la implementación de un programa de administración de antimicrobianos optimiza el uso seguro de esta importante clase de medicamentos.O uso indiscriminado e excessivo de antimicrobianos contribui diretamente para o desenvolvimento da resistência bacteriana, elevando as despesas com tratamentos, os índices de morbimortalidade, o tempo de internação e a ocorrência de reações adversas diversas. O objetivo do estudo foi avaliar e quantificar o consumo de antimicrobianos utilizados na UTI de um Hospital Público Federal. Estudo descritivo, transversal e retrospectivo realizado na Unidade de Terapia Intensiva (UTI) de um Hospital Universitário Federal da região Norte, durante o período de janeiro a dezembro de 2020. O consumo dos antimicrobianos foi expresso em Dose Diária Definida (DDD) por 1000 pacientes/dia. Utilizou-se a classificação ATC/ DDD da Organização Mundial de Saúde (OMS).  Ao total 190 pacientes estiveram internados na Unidade de Terapia Intensiva, dentre os quais 51% do sexo masculino, com média de idade de 53,4 ± 17,76 anos, sendo a faixa etária mais prevalente entre 60 e 74 anos (30,5%). Dentre as hipóteses diagnósticas de internação, 26% foi de infecção por coronavírus. Dos pacientes internados, 35,71% utilizaram algum tipo de tratamento com antimicrobiano, sendo o meropenem o mais consumido (DDD 225,24). O estudo da utilização de antimicrobianos é uma importante ferramenta tanto para nortear as ações do SCIH (Serviço de Controle de Infecção Hospitalar) que minimizem a resistência microbiana e o uso indiscriminado e irracional destes medicamentos quanto pelo aspecto econômico. Além disso, a implantação de um programa de stewardship de antimicrobianos otimiza o uso seguro dessa importante classe de fármacos.Research, Society and Development2022-03-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2759210.33448/rsd-v11i5.27592Research, Society and Development; Vol. 11 No. 5; e0611527592Research, Society and Development; Vol. 11 Núm. 5; e0611527592Research, Society and Development; v. 11 n. 5; e06115275922525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/27592/24257Copyright (c) 2022 Maria Gorete Lima Marinho; Suzany Helena da Silva Cândido; Mírian Brasil Magalhães de Oliveira; Rebeka Caribé Badinhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMarinho, Maria Gorete Lima Cândido, Suzany Helena da Silva Oliveira, Mírian Brasil Magalhães de Badin, Rebeka Caribé2022-04-17T18:18:56Zoai:ojs.pkp.sfu.ca:article/27592Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:45:16.612918Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region
Estudio de consumo de antimicrobianos en el Centro de Cuidados Intensivos de un Hospital Universitario de la Región Norte
Estudo de consumo de antimicrobianos do Centro de Terapia Intensiva de um hospital Universitário da Região Norte
title Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region
spellingShingle Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region
Marinho, Maria Gorete Lima
Unidad de Cuidados Intensivos
Consumo de antimicrobianos
Multirresistencia microbiana.
Intensive Care Center
Antimicrobial consumption
Microbial resistance.
Unidade de Terapia Intensiva
Consumo de antimicrobianos
Multirresistência microbiana.
title_short Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region
title_full Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region
title_fullStr Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region
title_full_unstemmed Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region
title_sort Study of antimicrobial consumption in Intensive Care Center of a University hospital in the North Region
author Marinho, Maria Gorete Lima
author_facet Marinho, Maria Gorete Lima
Cândido, Suzany Helena da Silva
Oliveira, Mírian Brasil Magalhães de
Badin, Rebeka Caribé
author_role author
author2 Cândido, Suzany Helena da Silva
Oliveira, Mírian Brasil Magalhães de
Badin, Rebeka Caribé
author2_role author
author
author
dc.contributor.author.fl_str_mv Marinho, Maria Gorete Lima
Cândido, Suzany Helena da Silva
Oliveira, Mírian Brasil Magalhães de
Badin, Rebeka Caribé
dc.subject.por.fl_str_mv Unidad de Cuidados Intensivos
Consumo de antimicrobianos
Multirresistencia microbiana.
Intensive Care Center
Antimicrobial consumption
Microbial resistance.
Unidade de Terapia Intensiva
Consumo de antimicrobianos
Multirresistência microbiana.
topic Unidad de Cuidados Intensivos
Consumo de antimicrobianos
Multirresistencia microbiana.
Intensive Care Center
Antimicrobial consumption
Microbial resistance.
Unidade de Terapia Intensiva
Consumo de antimicrobianos
Multirresistência microbiana.
description The indiscriminate and excessive use of antimicrobials directly contributes to the development of bacterial resistance, increasing treatment expenses, morbidity and mortality rates, hospitalization time, and various adverse reactions. Therefore, the study's objective was to evaluate and quantify the consumption of antimicrobials used in the ICU of a Federal Public Hospital. Antimicrobial consumption was expressed as a defined daily dose (DDD) per 1000 patients/day. It was used in the World Health Organization (WHO) ATC/DDD classification. A total of 190 patients were admitted to the Intensive Care Unit, among which 51% were male, with a mean age of 53.4 ± 17.76 years, with the most prevalent age group being between 60 and 74 years (30.5 %). Among the diagnostic hypotheses of hospitalization, 26% were coronavirus infections. Of the hospitalized patients, 35.71% used some antimicrobial treatment, with meropenem being the most consumed (DDD 225.24). The study of the use of antimicrobials is an essential tool to guide the actions of the SCIH (Hospital Infection Control Service) that minimize microbial resistance and the indiscriminate and irrational use of these drugs and for the economic aspect. Furthermore, implementing an antimicrobial stewardship program optimizes the safe use of this important class of drugs.
publishDate 2022
dc.date.none.fl_str_mv 2022-03-27
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/27592
10.33448/rsd-v11i5.27592
url https://rsdjournal.org/index.php/rsd/article/view/27592
identifier_str_mv 10.33448/rsd-v11i5.27592
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/27592/24257
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 5; e0611527592
Research, Society and Development; Vol. 11 Núm. 5; e0611527592
Research, Society and Development; v. 11 n. 5; e0611527592
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052707804020736